CoChat

Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates

Marcos-Zambrano, Laura Judith, Escribano, Pilar, Sánchez-Carrillo, Carlos, Bouza, Emilio, Guinea, Jesús · 2016 · Medical Mycology

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Trailing is a well-known phenomenon that is defined as reduced but persistent visible growth of Candida spp. at fluconazole concentrations above the MIC. Trailing is commonly detected using the CLSI M27-A3 method, although little is known about its frequency when investigated with EUCAST. We assessed the frequency and scope of fluconazole trailing after using EUCAST EDef 7.2. against a large number of Candida spp. isolates from patients with candidemia. We studied 639 fluconazole-susceptible non-krusei Candida spp. isolates from 570 patients admitted to Gregorio Marañón Hospital. Isolates were tested in vitro for fluconazole susceptibility according to the EUCAST EDef 7.2 procedure; trailing was defined as the presence of any residual growth in wells containing fluconazole concentrations above the MIC. According to the mean percentage of trailing observed, isolates were classified as residual trailers (0.1-5%), slight trailers (6%-10%), moderate trailers (11%-15%), and heavy trailers (>15%). The relationship between trailing and genotyping was assessed. The mean overall percentage of trailing was 6.8%, with C. albicans and C. tropicalis showing the highest percentages (9.75% and 9.29%, respectively; P < .001). C. albicans and C. tropicalis had the highest percentage of heavy trailers (>15%). Trailing was not genotype-specific. Fluconazole trailing was observed frequently when EUCAST was used for antifungal susceptibility testing, particularly in isolates of C. albicans and C. tropicalis The cut-off proposed enabled us to classify the isolates according to the degree of trailing and can be used as the basis for future studies to evaluate the clinical impact of this phenomenon.

Overview

Integrity signals

Registry

Crossref · 10.1093/mmy/myw033

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. 10.1046/j.1439-0507.2001.00603.x · doi:10.1046/j.1439-0507.2001.00603.x

Cited by

See all 37

Metadata

Authors
Marcos-Zambrano, L. J., Escribano, P., Sánchez-Carrillo, C., Bouza, E., & Guinea, J.
Affiliations
  • Hospital General Universitario Gregorio Marañón (ES)
  • Universidad Complutense de Madrid (ES)
Corresponding author
Guinea, Jesús
Venue
Medical Mycology
Published
2016-05-09
Volume
54
Issue
7
Pages
733-739
ISSN
  • 0268-1218 (ISSN-L)
  • 1369-3786
  • 1460-2709
OpenAlex
W2346365539
Cited by
33
References
21
Citations by year
2026: 5 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 1
FWCI
2.77
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Mycology (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • CM-SANTANDER (GR3/2014; group 920200)
  • Fondo de Investigación Sanitaria (PI14/00740)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords
Candida, candidemia, antifungal susceptibility testing, fluconazole susceptibility, Candida albicans, Candida tropicalis, residual growth, genotyping
MeSH terms
Antifungal Agents, Candida, Drug Tolerance, Genotype, Hospitals, Humans, Microbial Sensitivity Tests, Spain, Fluconazole, Candidemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates. https://app.cochat.ai/papers/10.1093/mmy/myw033
The paper
Marcos-Zambrano, L. J., Escribano, P., Sánchez-Carrillo, C., Bouza, E., & Guinea, J. (2016). Scope and frequency of fluconazole trailing assessed using EUCAST in invasive Candida spp. isolates. Medical Mycology. https://doi.org/10.1093/mmy/myw033

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.